7
May 2026
Antibodies.com awarded King's Award for Enterprise in International Trade
Antibodies.com has been awarded a 2026 King's Award for Enterprise in the International Trade category – one of the UK's highest business honors.
Stay Informed!
6
May 2026
Largest blood protein genetics study reveals new precision medicine opportunities
Involving a collaboration with 118 investigators contributing from 89 institutions, scientists from Queen Mary University of London's Precision Healthcare University Research Institute and Berlin Institute of Health (BIH) at Charité have led the world's largest study on the genetic regulation of blood proteins.
6
May 2026
GLP-1 drugs may reshape how brain values rewarding foods
A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does more than suppress appetite-it directly alters brain circuits that control motivation and reward.
6
May 2026
New study tracks HIV care after hospital discharge statewide
Sarah Rutstein, MD, PhD, and Thibaut Davy‑Mendez, PhD, MSPH, with the Institute for Global Health and Infectious Diseases have received an R01 from the National Institute of Mental Health (NIMH) at the National Institutes of Health (NIH).
6
May 2026
Researchers identify new treatment vulnerabilities in pancreatic cancer progression
The review offers important insights for patients and families by explaining why pancreatic cancer has proven so resistant to treatment, and where new hope may emerge.
6
May 2026
New CRISPR system selectively destroys cancer cells
Among the challenges in treating disease, including cancer, is wiping out malignancies, infection, contaminants or other pathologies, without destroying healthy tissue.
6
May 2026
Repeated head impacts linked to gut microbiome changes in athletes
Non-concussive head impacts-hits to the head that don't cause clinically detectable symptoms-are correlated with subsequent changes to the gut microbiome in a small sample of US collegiate football players, according to a new study published May 6, 2026, in the open-access journal PLOS One by Ahmet Ay and Kenneth Douglas Belanger of Colgate University, USA, and colleagues.
6
May 2026
CGRP inhibitors may reduce glaucoma risk among migraine patients
A type of drug used to prevent migraine may be associated with a reduced risk of glaucoma, according to a study published May 6, 2026, in Neurology®, the medical journal of the American Academy of Neurology.
6
May 2026
New immunotherapy strategy overcomes resistance in colorectal cancer treatment
Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have identified a promising new strategy to overcome resistance to immunotherapy in colorectal cancer, one of the leading causes of cancer-related deaths worldwide.
6
May 2026
Daily peanut exposure shows success in treating toddler allergies
Researchers at Karolinska Institutet have successfully treated children aged 1–3 years with peanut allergies. The children slowly became accustomed to eating peanuts by consuming small amounts of them daily, which were gradually increased over time.
